Sahlgrenska University Hospital begins recruiting patients

Nov 6, 2024
1 min read

(November 6) Sahlgrenska University Hospital has started recruiting patients for the REDUSE trial. As one of Sweden's largest hospitals, Sahlgrenska University Hospital is a key contributor to medical research and innovation. The hospital's extensive experience in highly specialized care (including emergency and critical care) and close collaboration with the Sahlgrenska Academy at the University of Gothenburg makes it well-positioned to participate in and contribute valuable data to the REDUSE trial.

Recent Posts

See All

Thesis defended by another REDUSE team member, Linn Hemberg

(March 31) Linn Hemberg, an environmental science researcher in perioperative and intensive care, defended her thesis, "Critical Care, Critical Emissions: Applying life cycle assessment on intensive a

Patient recruitment for the REDUSE trial begins at Malar Hospital (Eskilstuna)

(March 20) This month, Malar Hospital in Eskilstuna became the most recent site to start patient recruitment for the REDUSE clinical trial. Malar Hospital (Mälarsjukhuset) is part of Region Sörmland's

REDUSE team member Maria Lengquist defends thesis

(March 19) The REDUSE trial is proud to acknowledge a doctoral dissertation to be generated by one of its group members: on March 13, 2026, Dr. Maria Lengquist, MD, a specialist in anesthesiology and

Comments